Source Pravda.Ru

India’s Ranbaxy won approval to make and sell the anti-diabetes drug in U.S.

Indian pharmaceutical giant Ranbaxy said Friday it had received final approval from the U.S. Food and Drug Administration to make and sell the anti-diabetes drug glimipiride in the United States.

Glimepiride is the generic equivalent of Sanofi Aventis SA's anti-diabetic agent Amaryl, whose patent just expired. The brand has annual sales of about $350 million (Ђ287 million). Officials at the FDA and Aventis could not be immediately reached for comment.

Ranbaxy said in a statement that it had received approval to sell the tablets in doses of 1 milligram, 2 milligrams, 3 milligrams, 4 milligrams, 6 milligrams and 8 milligrams, reports the AP. I.L.

Comments
Africa's heart bleeds, who is to blame?
How Russia can respond to Israel following Ilyushin Il20 shootdown
Africa's heart bleeds, who is to blame?
Woman sucks her men dry in bed like female spider
China wages trade war against US, remains largest investor in US debt
Russia mourns victims of Ilyushin Il-20 shootdown
How Russia can respond to Israel following Ilyushin Il20 shootdown
How Russia can respond to Israel following Ilyushin Il20 shootdown
Russia mourns victims of Ilyushin Il-20 shootdown
NATO's 5,000 warplanes ready to bomb Russia, Chinese media say
Ukraine's Poroshenko signs decree to terminate Treaty of Friendship with Russia
Ukraine's Poroshenko signs decree to terminate Treaty of Friendship with Russia
Putin speaks about God and warns Ukraine
Putin speaks about God and warns Ukraine
How Russia can respond to Israel following Ilyushin Il20 shootdown
Russia obediently sells RD-180 rocket engines to USA if and when requested
Russia obediently sells RD-180 rocket engines to USA if and when requested
Russia mourns victims of Ilyushin Il-20 shootdown
53 million Russians may lose their jobs within a few years
How Russia can respond to Israel following Ilyushin Il20 shootdown
MiG-31 supersonic fighter jet crashes in Central Russia, pilots eject